Selecting esophageal cancer patients for lymphadenectomy after neoadjuvant chemoradiotherapy: a modeling study
Objectives Two-thirds of patients do not harbor lymph node (LN) metastases after neoadjuvant chemoradiotherapy (nCRT). Our aim was to explore under which circumstances a selective lymph node dissection (LND) strategy, which selects patients for LND based on the restaging results after nCRT, has adde...
Main Authors: | Didi JJM de Gouw, Bastiaan R Klarenbeek, Camiel Rosman, Janneke PC Grutters |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-10-01
|
Series: | BMJ Surgery, Interventions, & Health Technologies |
Online Access: | https://sit.bmj.com/content/2/1/e000027.full |
Similar Items
-
Extent and consequences of lymphadenectomy in oesophageal cancer surgery: case vignette survey
by: Didi JJM de Gouw, et al.
Published: (2020-10-01) -
Prognostic Effect of the Dose of Radiation Therapy and Extent of Lymphadenectomy in Patients Receiving Neoadjuvant Chemoradiotherapy for Esophageal Squamous Carcinoma
by: Chu-Pin Pai, et al.
Published: (2022-08-01) -
Survival and complications after neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for esophageal squamous cell cancer: A meta-analysis.
by: Yaru Guo, et al.
Published: (2022-01-01) -
The effectiveness of neoadjuvant chemoradiotherapy in oesophageal adenocarcinoma with presence of extracellular mucin, signet‐ring cells, and/or poorly cohesive cells
by: Maria J Valkema, et al.
Published: (2023-07-01) -
The value of tumor-stroma ratio as predictor of pathologic response after neoadjuvant chemoradiotherapy in esophageal cancer
by: G.W. van Pelt, et al.
Published: (2020-01-01)